These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2894520)

  • 1. Response to monoclonal CD7 antibody in rheumatoid arthritis.
    Kirkham B; Chikanza I; Pitzalis C; Kingsley GH; Grahame R; Gibson T; Panayi GS
    Lancet; 1988 Mar; 1(8585):589. PubMed ID: 2894520
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody treatment in rheumatoid arthritis: the clinical and immunological effects of a CD7 monoclonal antibody.
    Kirkham BW; Pitzalis C; Kingsley GH; Chikanza IC; Sabharwal S; Barbatis C; Grahame R; Gibson T; Amlot PL; Panayi GS
    Br J Rheumatol; 1991 Dec; 30(6):459-63. PubMed ID: 1720991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunomodulating therapy of rheumatoid arthritis (chronic polyarthritis): use of monoclonal antibodies].
    Horneff G; Burmester GR
    Z Rheumatol; 1995; 54(2):96-104. PubMed ID: 7540786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis.
    Kirkham BW; Thien F; Pelton BK; Pitzalis C; Amlot P; Denman AM; Panayi GS
    J Rheumatol; 1992 Sep; 19(9):1348-52. PubMed ID: 1279168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel treatment for rheumatoid arthritis.
    Denman AM
    Br J Rheumatol; 1992 Sep; 31(9):577-9. PubMed ID: 1525623
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibody treatment of rheumatoid arthritis.
    Kingsley G
    Br J Rheumatol; 1991; 30 Suppl 2():33-5. PubMed ID: 1993255
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
    Kyle V; Coughlan RJ; Tighe H; Waldmann H; Hazleman BL
    Ann Rheum Dis; 1989 May; 48(5):428-9. PubMed ID: 2786388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells.
    Chen G
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):27-36. PubMed ID: 20049648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of targeting adhesion molecules in rheumatoid arthritis.
    Haskard DO
    Cell Adhes Commun; 1994 Jul; 2(3):235-8. PubMed ID: 7827960
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy in rheumatoid arthritis: a review.
    Vitali C; Sciuto M; Bombardieri S
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():196-200. PubMed ID: 8013988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New treatments of rheumatoid arthritis for future use].
    Cantagrel A; Mazières B
    Rev Rhum Ed Fr; 1993 May; 60(5 Pt 2):45S-52S. PubMed ID: 8162008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possibilities for the immunotherapy of rheumatoid arthritis.
    Breedveld FC; De Vries RR
    Clin Rheumatol; 1990 Jun; 9(2):171-5. PubMed ID: 2202541
    [No Abstract]   [Full Text] [Related]  

  • 13. Attacking arthritis. New treatments seek to rebalance the immune system.
    Nemecek S
    Sci Am; 1997 Jun; 276(6):41. PubMed ID: 9163940
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospects in the immunological treatment of rheumatoid arthritis.
    Bach JF; Jacob L
    Clin Rheum Dis; 1984 Aug; 10(2):219-27. PubMed ID: 6391791
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibody therapy in rheumatic disease.
    Pitzalis C; Choy E; Kingsley G
    Presse Med; 1994 Mar; 23(11):532-9. PubMed ID: 8022742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell targetted immunotherapy with monoclonal antibodies in rheumatoid arthritis.
    Wither J
    J Rheumatol; 1992 Sep; 19(9):1330-2. PubMed ID: 1432996
    [No Abstract]   [Full Text] [Related]  

  • 17. [New therapeutic possibilities. Future aspects].
    Rubbert A; Burmester GR
    Internist (Berl); 1993 Sep; 34(9):841-51. PubMed ID: 8407201
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.
    Choy EH; Schantz A; Pitzalis C; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 Jul; 37(7):801-2. PubMed ID: 9714366
    [No Abstract]   [Full Text] [Related]  

  • 19. [Altered T-cells against rheumatoid arthritis. Markers as tools for early prognosis].
    Orn P
    Lakartidningen; 1996 Feb; 93(7):570-3. PubMed ID: 8642917
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted therapies for patients with rheumatoid arthritis.
    Oliver S; Mooney J
    Prof Nurse; 2002 Aug; 17(12):716-20. PubMed ID: 12229045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.